R&D Scientific is an artificial intelligence and research company focused on using AI and machine learning to accelerate drug discovery and development. It works with experts across digital science, research laboratories, and biomedicine to help researchers turn complex biological data into useful insights. Its stated research areas span fields such as genomics, systems biology, bioinformatics, cancer biology, clinical trials, and neuroscience.

The company offers diagnostic assessments that incorporate genetic testing, along with support for personalized health insights and analysis of large datasets. Example applications include assessing health risks from smartwatch data, improving breast cancer detection through medical imaging, interpreting RNA sequencing for therapeutic research, and creating cellular atlases from microscopy.

R&D Scientific also presents a range of research platforms and tools, including PandaOMICs for omics data analysis, Chemistry42 for drug discovery, SpliceCore for RNA sequencing, and resources such as AlphaFold, SciPy, NumPy, and MDAnalysis. Its work aims to deepen understanding of biology and disease, improve research efficiency, and contribute to innovations in personalized medicine and healthcare.